Due Diligence - Virtual CourseThree Part Series - Nov. 12, Nov. 14, Nov. 19, 2024
- November 12 - 11:00 am - 1:00 pm EASTERN
- November 14 - 11:00 am - 1:00 pm EASTERN
- November 19 - 11:00 am - 12:30 pm EASTERN
Please note: We do not provide recordings of our professional development courses - attendance is expected. Level: Intermediate – Some experience, typically 1-3 years, with IP licensing and interest in specific topics. Description: Due diligence is the research conducted prior to engaging in a business transaction. This course will provide guidance on how to develop and implement a due diligence strategy for a deal involving intellectual property (IP). It will discuss the What, When, Where, Who and How to perform due diligence depending on the deal and its importance to your organization. Modules: - Technical due diligence
- Legal due diligence
- Commercial and financial due diligence
- Live interactive case study with breakout groups
You will learn the following topics: - Ways to evaluate technology lifecycle, maturity, and technical readiness
- Ownership, remaining legal life of IP assets, freedom to operate
- Understanding market size, market growth, pricing
- What questions to ask and who to work with
What previous attendees have said: Recommended LES courses to take in advance or equivalent experience: Recommended LES courses to take after: - Foundations in IP Valuation
- Mechanics of a License
- Strengthening Your License
Course Creators & Contributors: Thank you to our course chair, past course chairs and content contributors who have developed and improved this course over time including: Pricing
Member Rate - $199.00
Non-Member Rate - $299.00
Student - $149.00 Group rates available for parties of 3 or more. Contact education@les.org for information. InstructorsMihaela Bojin, Ph.D., CLP, Senior Associate Director, University of Iowa Research Foundation Mihaela Bojin is a Senior Associate Director at the University of Iowa Research Foundation (UIRF). She has extensive expertise in intellectual capital management (licensing, business and intellectual property assessment, partnerships) in a variety of areas, such as pharmaceuticals, drug delivery, medical devices, and software. Mihaela is a Certified Licensing Professional (CLP) and a registered patent agent with the U.S. Patent and Trademark Office. Since 2020, she has been included in the IAM Strategy 300, an elite global group of IP strategists. Prior to joining UIRF, Mihaela was a patent agent at a New York City Intellectual Property Practice Group, an assistant professor on tenure track at the City University of New York, and a postdoctoral scholar at the University of California, Davis, and at New York University. Mihaela holds a PhD in Theoretical Chemistry from Cornell University, and a BSc in Chemistry from University of Bucharest, Romania. Connect on LinkedIn Gillian M. Fenton, Esq., CLP, Executive Director, LST Strategies LLC Gillian M. Fenton, Esq., CLP has been a member of the Licensing Executives Society (LES, USA & Canada) since 1992, and served as the society President in 2020-2021. Gillian’s contributions to LES and to the field of licensing were recognized with the society’s Frank Barnes Award in October 2022 and with listing in the IAM 300 in October 2023. She presently serves as U.S. Counsel to LESI and is a member of the LES USA & Canada Public Policy Committee and Course Chair for IP Licensing Basics. Gillian is the founder and executive director of LST Strategies LLC, a solo law practice dedicated to life science transactions. For the prior 8 years, she was GSK Vaccines Special Counsel for Innovation and Government Collaborations. At GSK, she supported a wide variety of business development transactions, R&D collaborations and U.S. Government Contracts including agreements with NIH/NIAID, BARDA, DARPA, CARB-X and NIIMBL. Before joining GSK, Gillian was VP, Associate General Counsel & Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and supported all IP aspects of the company’s IPO and subsequent 9 years of growth through M&A in the vaccines, biodefense, and global health fields. Gillian also spent over ten years in private practice at law firms in Boston, MA and Washington, DC. Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College.
Admissions: MA, MD, DC. Registered U.S. Patent Attorney. Connect on LinkedIn Jonathon K. Hance, Esq., CLP, Partner, Bracewell LLC Jonathon Hance is both a litigator and an intellectual property lawyer. As a litigator, Jonathon is at home in the court room, where he represents both plaintiffs and defendants and works hard to enforce his clients' intellectual property rights and data confidentiality rights, to protect his clients' brands, to bring value to his clients in the restructuring context, and to resolve complex commercial disputes in the design and construction, real estate, energy, healthcare, and technology industries. Connect on LinkedIn Lalit Gaur, CLP, Global Head Business Development and Licensing, VITOQUINOL Lalit Gaur, MBA, CLPTM is a seasoned business development and licensing executive with over 20 years of proven track record in leading business development and licensing (BD&L) transactions, alliances, strategy, and deal making. Currently, as Global Head of BD&L, Lalit leads a team responsible for executing BD&L transactions and strategy for VETOQUINOL, one of the globally leading pharmaceutical companies focused on animal health. Prior to joining VETOQUINOL, Lalit led and founded a management consulting advising clients ranging from governments to startup on BD&L transactions. Lalit has served in many BD&L capacities and across many segments of the life sciences industry. He started his career in human medical diagnostics, then to life sciences research and on to leading BD&L for Novartis AH, then to his current role. Lalit has been a member of the Licensing Executives Society for more than 15 years and currently serves as Chair of the Life Sciences Sector. Over the last decade or so, Lalit has remained very active with life sciences serving as a mentor, a judge to the business plan competition, and co-chair of many sub-committees in the Life Sciences Sector. He earned an MBA from Rice University and MS in Biology (Molecular) from Texas A&M. Connect on LinkedIn Samuel Mercer, Consultant, President, Vancouver Island Life Sciences Samuel Mercer has over 20 years of global pharmaceutical development experience, previously managing external agreements and outsourcing in the areas of multinational clinical trials, IT and scientific consulting, academic alliances, and pharma licensing, and negotiating directly over USD 600 million in varied external agreements for both Roche and Novartis in Basel, Switzerland. Prior to this, he managed proposals, contracts, and business development at several global contract research organizations in the UK and US. More recently, he is a management consultant, interim executive, board member, and advisor to a number of biotechnology and software/tech startups. His focus is on technology and IP development, clinical trial strategy, financial modelling, startup-company strategy and funding, and negotiating and managing of complex business agreements. Connect on LinkedIn
CANCELLATION and REFUND POLICY:No refunds will be granted for this education session. LES regrets that refunds will not be given for no-shows. A transfer of your full registration to another individual is permitted prior to the course by submitting written request to education@les.org. The individual submitting the transfer request is responsible for all financial obligations (any balance due) associated with that substitution. Funds from this program cannot be transferred to another education session without prior management approval. EMAIL CONSENT:By registering for this event, you permit LES to use your email address to communicate with you regarding LES events and their other services. You will have the ability to unsubscribe from these communications going forward. PHOTOGRAPHY CONSENT:By registering for this event, you permit LES to use photographs of you with or without your name and for any lawful purpose, including for example such purposes as publicity, illustration, advertising, and web content.
|
Print Page
